Despite a slowdown caused by macroeconomic and geopolitical forces in the second half of the year, 2022 was still the second-best year on record for healthcare dealmaking due in large part to the white-hot pace of investment at the start of the year. Total disclosed deal value reached nearly $90 billion, down from $151 billion in 2021 but still over $10 billion more than the next-closest year.
Read MoreFrost & Sullivan recognizes Validic, Inc. with the 2021 North America Company of the Year Award. Its scalable, secure solutions help improve operational efficiencies and health outcomes by seamlessly delivering data and real-time insights from hundreds of home health devices into existing clinical workflows.
Read MoreMore than 60% of providers struggle to derive optimal value from their electronic health records (EHRs), and 85% believe the increase in consumer self-pay will continue to impact their organizations, a Navigant analysis has found. The analysis is based on an executive survey of 108 hospital and health system chief financial officers and revenue cycle executives conducted by Healthcare Financial Management Association (HFMA).
Read More